Regenerative Medicine for Joint Pain: A Plain-English Guide
How regenerative options such as PRP, stem cell therapy, and exosomes compare with conventional joint care, and what the evidence and regulation say.
Joint pain is one of the most common reasons adults seek medical care. Many people try rest, physical therapy, medication, and injections. Regenerative medicine has become an additional topic of conversation. This guide explains the options and, importantly, what we do and do not know.
Common Causes of Joint Pain
•Osteoarthritis: gradual wear of cartilage and changes in the surrounding joint tissues
•Injury: meniscus, ligament, labrum, or tendon damage
•Inflammatory arthritis, such as rheumatoid arthritis, which needs specialist care
•Overuse and mechanical problems
Because causes differ, diagnosis comes first. Pain with fever, a hot swollen joint, or an inability to bear weight needs prompt medical attention.
Start With Conventional Care
First-line care is well supported: weight management, targeted exercise and physical therapy, activity modification, bracing, and appropriate medications. Many people do well with these alone. For advanced damage, procedures including joint replacement can be highly effective, and regenerative options are not a substitute when surgery is truly needed.
Regenerative Options, Compared
•Platelet-rich plasma (PRP): made from your own blood, concentrated for platelets and growth factors, then injected. It is the most widely studied of the group, with mixed results. The American College of Rheumatology's 2026 osteoarthritis guideline update strongly recommends against both PRP and stem cell injections for knee and hip osteoarthritis.
•Cell-based therapies, including Wharton's Jelly-derived MSC products: studied for their signaling and anti-inflammatory effects. Evidence is early and variable. See our Wharton's Jelly explainer.
•Exosome therapy: exosomes are tiny vesicles cells use to communicate. Interest is growing, but human evidence for joint use is very limited.
What to Know About Regulation and Evidence
The FDA has not approved stem cell or exosome products for treating arthritis or other joint conditions, and these uses are generally considered investigational. Studies to date are mostly small and vary in quality, and outcomes differ from person to person. For independent background, see the FDA's consumer guidance and the ISSCR's patient resources.
Questions to Ask Any Provider
•What evidence supports this for my specific condition?
•What are the risks, and what are the alternatives?
•What outcomes can I realistically expect, and how will we measure them?
•What does the total cost include?
Supporting Any Treatment
•Stay active within your limits, with low-impact exercise
•Maintain a healthy weight, since excess weight adds load to knees and hips
•Sleep well and manage stress
•Follow your clinician's aftercare and rehab instructions
•Track symptoms so you and your clinician can see what's changing
